We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

One company, two stories

26 October 2016 By Olaf Storbeck

The German chemical giant’s quarterly results beat expectations for the third time running. Bayer’s shares have been dragged down regardless by its overpriced $66 bln takeover of Monsanto. It would take fanciful improvements in performance to make good the $15 bln of lost value.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)